News round-up by DDW Editor Reece Armstrong for 15-19 August.
Covid booster approvals, positive results for Malaria vaccines and new CEOs are some of the stories in this week’s news round-up.
MHRA approves Moderna’s bivalent Covid booster
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s Covid-19 booster vaccine that targets two coronavirus variants.
Positive results for US Malaria vaccine, trial shows
A monoclonal antibody (mAb) treatment for the prevention of Malaria has shown encouraging results in a US Phase I clinical trial.
Sanofi signs $20m research agreement with Atomwise
Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of up to five drug targets.
EMA approves early-stage breast cancer treatment
A precision medicine for early-stage breast cancer has been approved by the European Medicines Agency (EMA).
Respira appoints new CEO to drive inhalable therapeutics
Clinical-stage company Respira Technologies has appointed a new Chief Executive Officer (CEO) to the company.
